Roles of KHDRBS2 and KHDRBS3 in prostate cancer progression and AR-V7 regulation
XuDong Yang, Xia Liu, Ran Xiao, YiLin Cao · 2025
Read Roles of KHDRBS2 and KHDRBS3 in prostate cancer progression and AR-V7 regulation by XuDong Yang, Xia Liu, Ran Xiao, YiLin Cao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12830514.txt.
Description
XuDong Yang, Xia Liu, Ran Xiao, and YiLin Cao study two RNA binding proteins in prostate cancer, in a paper from 2025. Advanced prostate cancer often stops answering hormone blocking care. A shortened form of the hormone receptor, called AR-V7, is a key driver of that resistance, and new ways to control it are badly needed.
The authors first mined public data sets for how the two proteins are expressed across prostate cancer types, including resistant and nerve like forms. Lab work in two cell lines, one with the hormone receptor and one without, tested how the proteins interact. Growth tests in dishes and in mice weighed their effect on tumors. Changing one protein's level shifted both AR-V7 and the full receptor, which links this pair to the resistance path.
Catalog record
| CREATOR | XuDong Yang, Xia Liu, Ran Xiao, YiLin Cao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |